Literature DB >> 17828348

Clinical outcome measures of psoriasis.

C Bonifati1, E Berardesca.   

Abstract

Several tools have been introduced in clinical trials to quantify the severity and the response to a given therapeutic regimen of both psoriasis and psoriatic arthritis. Each method present specific advantages and limitations. Here we will discuss some of the most popular clinical outcome measures of both psoriasis (Psoriasis Severity Index, Physician Global Assessment, National Psoriasis Fundation-Psoriasis Score, Dermatology Life Quality Index) and psoriatic arthritis (American College Rheumatology response criteria, Psoriatic Arthritis Response Criteria).

Entities:  

Mesh:

Year:  2007        PMID: 17828348     DOI: 10.4081/reumatismo.2007.1s.64

Source DB:  PubMed          Journal:  Reumatismo        ISSN: 0048-7449


  2 in total

1.  Autologous serum therapy in chronic urticaria: a promising complement to antihistamines.

Authors:  Panchami Debbarman; Amrita Sil; Piyush Kanti Datta; Debabrata Bandyopadhyay; Nilay Kanti Das
Journal:  Indian J Dermatol       Date:  2014-07       Impact factor: 1.494

2.  An Investigator-Blind Randomized Controlled Trial Comparing Effectiveness, Safety of Levocetirizine and Bepotastine in Chronic Urticaria.

Authors:  Amrita Sil; Sufiur Rahaman; Nasiruddin Mondal; Sk Shahriar Ahmed; Dhiman Tarafdar; Aparesh Chandra Patra; Sudipta Roy; Nilay Kanti Das
Journal:  Indian J Dermatol       Date:  2021 Sep-Oct       Impact factor: 1.494

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.